Fairvalue-Calculator Fairvalue-Calculator
EN DE

Penetrium Bioscience Inc (187660) Fair Value & Analysis

Healthcare · KR · Market cap 347B KRW

Price5,600 KRW
Fair Value1,768 KRW
Upside-68.4%
Quality95/100
Evidence: Low Range 1,326 KRW – 2,210 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Penetrium Bioscience Inc (187660) currently trades at 5,600 KRW, while our model-based Fair Value estimate is 1,768 KRW — implying the stock looks roughly 68.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Penetrium Bioscience Inc., a contract research organization, provides clinical-related professional services for customer requirements in South Korea. The company offers clinical development services, such as medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs. It also provides pharmacovigilance services, which include case processing and safety reporting, safety and risk management plans, aggregate reporting, literature screening, and medical device vigilance; and quality assurance services. The company was formerly known as Hyundai ADM Bio Inc. and changed its name to Penetrium Bioscience Inc. in March 2026. Penetrium Bioscience Inc. was founded in 2003 and is based in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) +19% Fresenius SE (FSNUY) -27% 5225 (5225) -39% IHHHF (IHHHF) -26% Rede D'Or São Luiz S.A (RDOR3) +37% Tenet Healthcare Corporation (THC) +86%

Frequently asked questions

Is Penetrium Bioscience Inc (187660) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 1,768 KRW versus a price of 5,600 KRW — about −68% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 187660?
Our 21-model fair value for Penetrium Bioscience Inc is 1,768 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 5,600 KRW.
What is the quality score of 187660?
Penetrium Bioscience Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.